TY - JOUR
T1 - TPPP-BRD9 fusion-related gallbladder carcinomas are frequently associated with intracholecystic neoplasia, neuroendocrine carcinoma, and a distinctive small tubular-type adenocarcinoma commonly accompanied with a syringomatous pattern
AU - Gallbladder Cancer Chile Working Group (GBCChWG)
AU - Pehlivanoglu, Burcin
AU - Araya, Juan Carlos
AU - Lawrence, Scott
AU - Roa, Juan Carlos
AU - Balci, Serdar
AU - Andersen, Jesper B.
AU - Rashid, Asif
AU - Hsing, Ann W.
AU - Zhu, Bin
AU - Gao, Yu Tang
AU - Koshiol, Jill
AU - Adsay, Volkan
AU - Miquel, Juan Francisco
AU - Acevedo, Johanna
AU - Cook, Paz
AU - Aguayo, Carmen Gloria
AU - Baez, Sergio
AU - Díaz, Alfonso
AU - Azócar, Lorena
AU - Molina, Héctor
AU - Miranda, Carolina
AU - Castillo, Claudia
AU - Tello, Andrea
AU - Toledo, Fernando
AU - Wozniak, Aniela
AU - Durán, Gonzalo
AU - Delgado, Carolina Paz
AU - Torres-Quevedo, Rodrigo
AU - Pineda, Susana
AU - Barra, Tiare de la
AU - Reyes, Cristian
AU - Alegría, Cristina
AU - Aguayo, Claudia
AU - Losada, Héctor
AU - Bellolio, Enrique
AU - Tapia, Oscar
AU - López, Jaime
AU - Medina, Karie
AU - Barraza, Paulina
AU - Catalán, Sandra
AU - Riquelme, Pía
AU - Órdenes, Lorena
AU - Garcés, Raúl
AU - Duarte, Claudia
AU - Hildesheim, Allan
N1 - Publisher Copyright:
© 2024
PY - 2024/8
Y1 - 2024/8
N2 - A fusion between tubulin polymerization-promoting protein (TPPP), a regulatory cytoskeletal gene, and the chromatin remodeling factor, bromodomain-containing protein 9 (BRD9), TPPP-BRD9 fusion has been found in rare cancer cases, including lung and gallbladder cancers (GBC). In this study, we investigated the histopathological features of 16 GBCs previously shown by RNA sequencing to harbor the TPPP-BRD9 fusion. Findings in the fusion-positive GBCs were compared with 645 GBC cases from the authors’ database. Among the 16 TPPP-BRD9 fusion-positive GBC cases, most were females (F:M = 7:1) of Chinese ethnicity (12/16), whereas the remaining cases were from Chile. The histopathological examination showed the following findings: 1) Intracholecystic neoplasm (ICN) in 7/15 (47% vs. 7% 645 reference GBCs, p < 0.001), all with gastro-pancreatobiliary phenotype, often with clear cell change, and in the background of pyloric gland metaplasia and extensive high-grade dysplasia. 2) Neuroendocrine carcinoma (NEC) morphology: 3 cases (27% vs. 4.6% in the reference database, p = 0.001) showed a sheet-like and nested/trabecular growth pattern of monotonous cells with salt-and-pepper chromatin characteristic of NECs. Two were large cell type, one had prominent clear cell features, a rare finding in GBNECs; the other one had relatively bland, well-differentiated morphology, and the remaining case was small cell type. 3) Adenocarcinoma identified in 8 cases had a distinctive pattern characterized by widely separated small, round tubular units with relatively uniform nuclei in a fashion seen in mesonephric adenocarcinomas, including hobnail-like arrangement and apical snouts, reminiscent of tubular carcinomas of the breast in many areas. In some foci, the epithelium was attenuated, and glands were elongated, some with comma shapes, which along with the mucinous/necrotic intraluminal debris created a “syringoid” appearance. 4) Other occasional patterns included the cribriform, glomeruloid patterns, and metaplastic tubular-spindle cell pattern accompanied by hemorrhage. In conclusion, TPPP-BRD9 fusion-positive GBCs often develop through intracholecystic neoplasms (adenoma-carcinoma sequence) of gastro-pancreatobiliary lineage, appear more prone to form NEC morphology and have a propensity to display clear cell change. Invasive adenocarcinomas arising in this setting often seem to display a distinctive appearance that we tentatively propose as the TPPP-BRD9 fusion-positive pattern of GBC.
AB - A fusion between tubulin polymerization-promoting protein (TPPP), a regulatory cytoskeletal gene, and the chromatin remodeling factor, bromodomain-containing protein 9 (BRD9), TPPP-BRD9 fusion has been found in rare cancer cases, including lung and gallbladder cancers (GBC). In this study, we investigated the histopathological features of 16 GBCs previously shown by RNA sequencing to harbor the TPPP-BRD9 fusion. Findings in the fusion-positive GBCs were compared with 645 GBC cases from the authors’ database. Among the 16 TPPP-BRD9 fusion-positive GBC cases, most were females (F:M = 7:1) of Chinese ethnicity (12/16), whereas the remaining cases were from Chile. The histopathological examination showed the following findings: 1) Intracholecystic neoplasm (ICN) in 7/15 (47% vs. 7% 645 reference GBCs, p < 0.001), all with gastro-pancreatobiliary phenotype, often with clear cell change, and in the background of pyloric gland metaplasia and extensive high-grade dysplasia. 2) Neuroendocrine carcinoma (NEC) morphology: 3 cases (27% vs. 4.6% in the reference database, p = 0.001) showed a sheet-like and nested/trabecular growth pattern of monotonous cells with salt-and-pepper chromatin characteristic of NECs. Two were large cell type, one had prominent clear cell features, a rare finding in GBNECs; the other one had relatively bland, well-differentiated morphology, and the remaining case was small cell type. 3) Adenocarcinoma identified in 8 cases had a distinctive pattern characterized by widely separated small, round tubular units with relatively uniform nuclei in a fashion seen in mesonephric adenocarcinomas, including hobnail-like arrangement and apical snouts, reminiscent of tubular carcinomas of the breast in many areas. In some foci, the epithelium was attenuated, and glands were elongated, some with comma shapes, which along with the mucinous/necrotic intraluminal debris created a “syringoid” appearance. 4) Other occasional patterns included the cribriform, glomeruloid patterns, and metaplastic tubular-spindle cell pattern accompanied by hemorrhage. In conclusion, TPPP-BRD9 fusion-positive GBCs often develop through intracholecystic neoplasms (adenoma-carcinoma sequence) of gastro-pancreatobiliary lineage, appear more prone to form NEC morphology and have a propensity to display clear cell change. Invasive adenocarcinomas arising in this setting often seem to display a distinctive appearance that we tentatively propose as the TPPP-BRD9 fusion-positive pattern of GBC.
KW - Gallbladder cancer
KW - Histopathology
KW - ICPN
KW - Syringomatous pattern
KW - TPPP-BRD9 fusion
UR - http://www.scopus.com/inward/record.url?scp=85198330859&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85198330859&partnerID=8YFLogxK
U2 - 10.1016/j.humpath.2024.07.001
DO - 10.1016/j.humpath.2024.07.001
M3 - Article
C2 - 38972607
AN - SCOPUS:85198330859
SN - 0046-8177
VL - 150
SP - 67
EP - 73
JO - Human Pathology
JF - Human Pathology
ER -